Skip to main content
CivicGate

HR 5999
Introduced Re-checks Congress.gov for new actions and updates the bill's status, and fills in any sponsors, committees, or related bills that are missing. It does not re-pull sponsors/cosponsors/committees/related — those rarely change — and it skips all work if nothing has changed upstream, so it's cheap to click.

To amend title 38, United States Code, to direct the Secretary of Veterans Affairs to furnish an opioid antagonist to a veteran without requiring a prescription or copayment.

To amend title 38, United States Code, to direct the Secretary of Veterans Affairs to furnish an opioid antagonist to a veteran without requiring a prescription or copayment.

Introduced Nov 10, 2025

Latest action (May 14, 2026) Ordered to be Reported (Amended) by Voice Vote.

Summary

This bill amends veterans benefits law to require the Department of Veterans Affairs to furnish opioid antagonists, such as naloxone, to eligible veterans. The antagonists must be provided without requiring a prescription. The bill also eliminates copayment requirements, ensuring veterans can access these overdose-reversal medications at no cost.

AI-generated plain-language summary of the bill text — neutral, and may be imperfect. See the full text below for the exact wording.

Sponsor (1)

Money behind the sponsor

Top reported contributors to Herbert C. Conaway’s campaign committee (2024 cycle) — who funds the bill’s sponsor, not a claim about this bill. Data from FEC.

  • RAMAS CONTRACTORS, LLC $13,200
  • NEUROSURGEONS OF NEW JERSEY $13,200
  • ASTERA $12,450
  • ALLIED DIGESTIVE HEALTH $10,900
  • STATE OF NEW JERSEY $10,450

Organizations whose employees gave the most — itemized individual contributions grouped by the donor’s reported employer (FEC Schedule A). Full finance for Herbert C. Conaway → · Outside spending →

Actions (8)

  1. May 14, 2026 Ordered to be Reported (Amended) by Voice Vote. · house
  2. May 14, 2026 Committee Consideration and Mark-up Session Held · house
  3. Apr 16, 2026 Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote. · house
  4. Apr 16, 2026 Subcommittee Consideration and Mark-up Session Held · house
  5. Jan 13, 2026 Subcommittee Hearings Held · house
  6. Nov 17, 2025 Referred to the Subcommittee on Health. · house
  7. Nov 10, 2025 Referred to the House Committee on Veterans' Affairs. · house
  8. Nov 10, 2025 Introduced in House

More bills on these subjects (8)

Other bills that carry the most legislative subjects in common with this one (topical discovery — distinct from the procedural related bills above).

Similar bills (6)

Bills with similar text or summary — includes reintroductions across Congresses. Ranked by semantic similarity of the bill text (computed locally); a neutral discovery aid, not a claim the bills are duplicates.

Text versions (1)

  • Introduced in House · Nov 10, 2025

Only one text version is on file, so there’s no earlier version to compare against yet.

Full text

IN THE HOUSE OF REPRESENTATIVES

November 10, 2025

Mr. Conaway (for himself and Ms. Morrison) introduced the following bill; which was referred to the Committee on Veterans’ Affairs

A BILL

To amend title 38, United States Code, to direct the Secretary of Veterans Affairs to furnish an opioid antagonist to a veteran without requiring a prescription or copayment.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. PROVISION BY THE SECRETARY OF VETERANS AFFAIRS OF AN OPIOID ANTAGONIST TO A VETERAN.

(a) Requirement.—Subchapter II of chapter 17 of title 38, United States Code, is amended by adding at the end the following new section (and amending the table of sections at the beginning of such chapter accordingly): “Sec. 1720M. Opioid antagonists. “The Secretary shall furnish an opioid antagonist to a veteran without requiring a prescription.”.

(b) Elimination of Copayment.—Section 1722A of such title is amended, in subsection (a)(4), by striking all that follows “veteran” and inserting a period. <all>

Comments

Comments

Loading comments…